期刊文献+

重组人干细胞因子对人类急性髓系白血病干/祖细胞自我更新作用的实验研究 被引量:3

EFFECT OF RECOMBINT HUAN STEM CELL FACTOR(rhSCF)ON SELF-RENEWAL OF STEM/PROGENTTOR CELLS OF HUMAN ACUTE MIYELOGENOUS LEUKEMIIA
原文传递
导出
摘要 应用无血清液体一半固体二次培养法,观察了重组人干细胞因子(recombinanthumanstemcellfactor,rhSCF)对人类急性髓系白血病干/祖细胞(AML-CFU)自我更新的影响。认为rhSCF是一作用阶段早于白介素3(IL-3)和粒/巨噬细胞集落刺激因子(GM-CSF)的造血生长因子(HGF)。无论单一,还是与其它HGF联合,rhSCF对绝大部分AML患者,均有强大的维持其AML-CFU自我更新的作用。但不同FAB亚型及FAB亚型相同的患者之间,这种维持作用差异较为显著。提示SCF在AML病理过程中起重要作用。 Abstract Using serum- free culture system and liquid/sem-solid dual culture technque, we examinedthe effect of rhsCF on self-renewal of the stem/progenitor cells of human acute myelogenousleukemia(AML- CFU).The results revealed that the rhSCF as a hematopoietic growth factor(HGF)exerted its effect hierarchically earlier than interleukin- 3and granulocyte/macriophage colo-ny-stimulating factor on AM L- CFU. rhSCF, whether used alone or in combination with otherHGFs, showed potential maintenance of self- renewal of AML- CFU in most AML patientsstudied. However,considerable discrepancy existed in maintenance among various FAB types of pa-tients or even in patients with the same FAB type. It is suggested that SCF may play an impor-tant role in the pathological development of AML.
出处 《中华肿瘤杂志》 CSCD 北大核心 1994年第4期259-262,共4页 Chinese Journal of Oncology
  • 相关文献

参考文献3

  • 1唐继森,国外医学输血及血液学分册,1992年,5卷,274页
  • 2Wang C,Leukemia,1989年,3卷,699页
  • 3Wang C,Blood,1987年,69卷,553页

同被引文献20

  • 1李川晟,程涛,许燕群.重组人干细胞因子对放射病患者造血细胞的体外作用[J].中华放射医学与防护杂志,1994,14(4):221-224. 被引量:8
  • 2黄强,董军,朱玉德,张全斌,季晓燕,王爱东,兰青.人脑胶质瘤组织中分离与培养肿瘤干细胞[J].中华肿瘤杂志,2006,28(5):331-333. 被引量:53
  • 3裴雪涛,王立生,徐黎,吴祖泽.造血生长因子对脐血CD34^+细胞的体外扩增作用[J].中华血液学杂志,1996,17(6):304-307. 被引量:32
  • 4Cantrell LA,Zhou C,Mendivil A,et al.Mefformin is a potent inhibitor of endometrial cancer cell proliferation:implications for a novel treatment strategy.Gynecol Oncol,2010,116:92-98.
  • 5Berstein LM.Metformin,insulin,breast cancer and more.Future Oncol,2009,5:309-312.
  • 6Ben Sahra I,Le Marchand-Brustel Y,Tanti JF,et al.Mefformin in cancer therapy:a new perspective for an old antidiabetic drug?.Mol Cancer Ther,2010,9:1092-1099.
  • 7Ma S,Lee TK,Zheng BJ,et al.CD133 + HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway.Oncogene,2008,27:1749-1758.
  • 8Ben Sabra I,Laurent K,Loubat A,et al.The antidiabetic drug mefformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level.Oncogene,2008,27:3576-3586.
  • 9Elrod HA,Lin YD,Yue P,et al.The alkylphospholipid perifosine induces apoptosis of human lung cancer cells requiring inhibition of Akt and activation of the extrinsic apoptotic pathway.Mol Cancer Ther,2007,6:2029-2038.
  • 10Cheng JQ,Lindsley CW,Cheng GZ,et al.The Akt/PKB pathway:molecular target for cancer drug discovery.Oncogene,2005,24:7482-7492.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部